Home › Companies › AbCellera Biologics Inc. › 2025-2026
At AbCellera Biologics Inc.'s shareholder meeting held June 11, 2026, in the 2025-2026 proxy season, 92 asset managers reported how they voted in their SEC Form N-PX filings, covering 177 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. AbCellera Biologics Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on a non-binding advisory basis, the compensation of the Company's named executive… — the reporting funds and managers cast 70% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and AbCellera Biologics Inc.’s Form 8-K, filed June 12, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 11, 2026: 4 items on AbCellera Biologics Inc.’s Form 8-K, filed June 12, 2026: 2 approved · 2 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore AbCellera Biologics Inc. in the interactive database Compare manager voting policies
These tallies are AbCellera Biologics Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 12, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: John S. Montalbano, CFA | 141,430,732 | 12,723,342 | 45,898 | -- | -- | 92% | Not verified | — |
| Elect Director: Stephen R. Quake, D.Phil. | 149,019,960 | 5,113,056 | 66,956 | -- | -- | 97% | Not verified | — |
| 2. Proposal 2 | 189,927,972 | 552,429 | 295,930 | -- | -- | 99.7% | Approved | — |
| 3. Proposal 3 | 142,831,950 | 10,932,105 | 435,917 | -- | -- | 93% | Approved | — |
Source: AbCellera Biologics Inc., Form 8-K, filed with the SEC on June 12, 2026 — read the filing on EDGAR.
Each item below shows how the 92 asset managers that disclosed a AbCellera Biologics Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of AbCellera Biologics Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: To elect two class III directors to our Board of Directors, to serve until the 2029 Annual Meeting of Shareholders or until their successors has been duly elected and qualified, or until their earlier death, resignation or removal: John S. Montalbano, CFA
AbCellera Biologics Inc.’s own tally for this item (“Elect Director: John S. Montalbano, CFA”): 141,430,732 for, 12,723,342 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 10,882,078 for, 558,937 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 10,328,596 | 0 | 0 | 0 | For |
| BlackRock | 507,697 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 0 | 249,240 | 0 | 0 | Against |
| RBB FUND, INC. | 0 | 120,162 | 0 | 0 | Against |
| American Century | 0 | 79,158 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 66,100 | 0 | 0 | Against |
| Brinker Capital Destinations Trust | 0 | 41,514 | 0 | 0 | Against |
| State Street | 36,589 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 5,289 | 0 | 0 | 0 | For |
| Fidelity | 3,227 | 0 | 0 | 0 | For |
| ProShares | 0 | 2,762 | 0 | 0 | Against |
| Invesco | 680 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 1 | 0 | 0 | Against |
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To elect two class III directors to our Board of Directors, to serve until the 2029 Annual Meeting of Shareholders or until their successors has been duly elected and qualified, or until their earlier death, resignation or removal: Stephen R. Quake, D.Phil.
AbCellera Biologics Inc.’s own tally for this item (“Elect Director: Stephen R. Quake, D.Phil.”): 149,019,960 for, 5,113,056 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 11,441,015 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 10,328,596 | 0 | 0 | 0 | For |
| BlackRock | 507,697 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 249,240 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 120,162 | 0 | 0 | 0 | For |
| American Century | 79,158 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 66,100 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 41,514 | 0 | 0 | 0 | For |
| State Street | 36,589 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 5,289 | 0 | 0 | 0 | For |
| Fidelity | 3,227 | 0 | 0 | 0 | For |
| ProShares | 2,762 | 0 | 0 | 0 | For |
| Invesco | 680 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 1 | 0 | 0 | 0 | For |
Combines 4 wordings of this item as funds reported it.
70% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, or Say-on-Pay;
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 0 | 10,328,596 | 0 | 0 | Against |
| BlackRock | 507,697 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 249,240 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 120,162 | 0 | 0 | 0 | For |
| American Century | 79,158 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 66,100 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 41,514 | 0 | 0 | 0 | For |
| State Street | 36,589 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 5,289 | 0 | 0 | 0 | For |
| Fidelity | 3,227 | 0 | 0 | 0 | For |
| ProShares | 2,762 | 0 | 0 | 0 | For |
| Invesco | 680 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 1 | 0 | 0 | 0 | For |
Fund voting reports, all 13 managers: 1,112,419 for, 10,328,596 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 30,275,938 | 0 | 0 | 0 | For |
| Capital Group | 0 | 10,328,596 | 0 | 0 | Against |
| ArrowMark Colorado Holdings LLC | 4,105,095 | 0 | 0 | 0 | For |
| Two Sigma | 4,039,582 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 3,434,902 | 0 | 0 | 0 | For |
| NICOLA WEALTH MANAGEMENT LTD. | 1,400,850 | 0 | 0 | 0 | For |
| BlackRock | 1,004,788 | 0 | 0 | 0 | For |
| Renaissance | 627,297 | 0 | 0 | 0 | For |
| Point72 | 615,094 | 0 | 0 | 0 | For |
| Lazard | 303,058 | 0 | 0 | 0 | For |
| Guardian Partners Inc. | 200,000 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 80,439 | 0 | 0 | 0 | For |
| PIER 88 INVESTMENT PARTNERS LLC | 79,900 | 0 | 0 | 0 | For |
| American Century | 79,158 | 0 | 0 | 0 | For |
| RBC Dominion Securities Inc. | 67,365 | 0 | 0 | 0 | For |
| Resolute Advisors LLC | 0 | 57,526 | 0 | 0 | Against |
| Northern Trust | 55,693 | 0 | 0 | 0 | For |
| State Street | 36,589 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 34,100 | 0 | 0 | 0 | For |
| CIBC Private Wealth Group LLC | 30,000 | 0 | 0 | 0 | For |
| BRANDYWINE MANAGERS, LLC | 28,488 | 0 | 0 | 0 | For |
| SCOTIA CAPITAL INC. | 22,025 | 0 | 0 | 0 | For |
| Green Alpha Advisors, LLC | 19,397 | 0 | 0 | 0 | For |
| CIBC Capital Markets (Europe) S.A. | 17,246 | 0 | 0 | 0 | For |
| CIBC WORLD MARKET INC. | 17,246 | 0 | 0 | 0 | For |
Institutional-manager reports, all 80 managers: 46,723,226 for, 10,404,617 against, 1,313 not voted. Showing the 25 largest; every one is in the interactive database (link above).
100% of fund votes cast · no official result
The 2 asset managers below reported 9,911,020 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TD Waterhouse Canada Inc. | 9,565,859 | 0 | 0 | 0 | For |
| SOFTBANK GROUP CORP. | 345,161 | 0 | 0 | 0 | For |
100% of fund votes cast · no official result
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;
The 13 asset managers below reported 11,441,015 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 10,328,596 | 0 | 0 | 0 | For |
| BlackRock | 507,697 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 249,240 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 120,162 | 0 | 0 | 0 | For |
| American Century | 79,158 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 66,100 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 41,514 | 0 | 0 | 0 | For |
| State Street | 36,589 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 5,289 | 0 | 0 | 0 | For |
| Fidelity | 3,227 | 0 | 0 | 0 | For |
| ProShares | 2,762 | 0 | 0 | 0 | For |
| Invesco | 680 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 1 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 305,375,393 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Group | 3.38% |
| 2 | BlackRock | 0.17% |
| 3 | DRIEHAUS MUTUAL FUNDS | 0.08% |
| 4 | RBB FUND, INC. | 0.04% |
| 5 | American Century | 0.03% |
| 6 | Blackstone Alternative Investment Funds | 0.02% |
| 7 | Brinker Capital Destinations Trust | 0.01% |
| 8 | State Street | 0.01% |
| 9 | MASTER INVESTMENT PORTFOLIO | <0.01% |
| 10 | Fidelity | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 9.91% |
| 2 | Capital Group | 3.38% |
| 3 | ArrowMark Colorado Holdings LLC | 1.34% |
| 4 | Two Sigma | 1.32% |
| 5 | DRIEHAUS CAPITAL MANAGEMENT LLC | 1.12% |
| 6 | NICOLA WEALTH MANAGEMENT LTD. | 0.46% |
| 7 | BlackRock | 0.33% |
| 8 | Renaissance | 0.21% |
| 9 | Point72 | 0.20% |
| 10 | Lazard | 0.10% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Carl L.G. Hansen, Ph.D. | 21.35% | DEF14A |
| Thermopylae Holdings Ltd. | 18.38% | DEF14A |
| Baker Bros. Advisors LP | 10.81% | 13G |
| Véronique Lecault, Ph.D. | 4.37% | DEF14A |
| Two Sigma | 3.46% | 13F |
| Andrew Booth | 2.28% | DEF14A |
| BlackRock | 1.32% | 13F |
| Goldman Sachs | 1.23% | 13F |
| Tryn Stimart | 1.06% | DEF14A |
| Morgan Stanley | 0.98% | 13F |
Percentages above are of 305,375,393 shares outstanding, as reported by AbCellera Biologics Inc. on its Form 10-Q dated May 7, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AbCellera Biologics Inc.’s 10-Q dated May 7, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
AbCellera Biologics Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
proxyvotesnow.com, “AbCellera Biologics (ABCL) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/abcellera-biologics-inc/2026 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.